New Delhi [India], October 7 (ANI): Following the approval of the Zydus Cadila vaccine by the Drugs Controller General of India (DGCI) for emergency use, Dr VK Paul, Member (Health) of Niti Aayog on Thursday said that the vaccine will be administered through an applicator which will be us
New Delhi [India], October 4 (ANI): Negotiation over the pricing of COVID-19 vaccine ZyCov-D between the central government and Zydus Cadila are still underway. The final decision is expected by this week, as per the government sources.
New Delhi [India], October 3 (ANI): Once the COVID-19 vaccination drive for children commences in India, priority would be given to children with comorbidities however severe, said National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora.
Pune (Maharashtra) [India], October 1 (ANI): Serum Institute of India (SII) has supplied 78 crore doses of its COVID-19 vaccine Covishield so far and its target is to supply almost 21.50 crore doses in the month of October, informed the sources to ANI on Friday.
New Delhi [India], September 16 (ANI): Secretary, Department of Biotechnology, Government of India Dr Renu Swarup said that Drugs Controller General of India has given permission to Christian Medical College, Vellore to start a trial on the mixing of COVID-19 vaccines while adding that th
New Delhi [India], September 14 (ANI): The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
New Delhi [India], September 12 (ANI): Considering the burden on healthcare and the expense of buying three doses, Zydus Cadila is planning to seek approval for the two-dose regimen of its needle-free COVID-19 vaccine, ZyCoV-D, days after the vaccine was approved by India's drugs regulator f
New Delhi [India], September 11 (ANI): Zydus Cadila's needle-free coronavirus vaccine-- ZyCoV-D-- is likely to be available by early October, sources told ANI on Saturday.
New Delhi [India], August 29 (ANI): Stating that India approved Zydus Cadila's DNA vaccine for emergency use in adults and children, Medanta Chairman and Managing Director Dr Naresh Trehan on Sunday cautioned against the re-opening of schools and said that since the vaccine is around the
New Delhi [India], August 23 (ANI): The Drugs Controller General of India (DCGI) on Friday approved Zydus Cadila's DNA vaccine for emergency use in adults and children aged 12 years and above.
New Delhi [India], August 21 (ANI): Managing Director of Zydus Group Dr Sharvil Patel on Saturday said that his firm will soon apply for the Indian drug regulator's approval to conduct trials of ZyCoV-D on children above 2 years and added that it will take another 4-5 months to publish the p
New Delhi [India], August 21 (ANI): There will be more clarity on the price of its COVID-19 vaccine ZyCOV-D by next week, said Managing Director of Zydus Group Dr Sharvil Patel on Saturday.